SC 13G Filing

Company

Traws Pharma, Inc.

Filed

January 10, 2020

Accession Number

0000919574-20-000305

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →